Thoughts from the void: Cannabis and South Dakota

The list of US states that have legalized adult recreational cannabis is available here.

Listed below are articles taken from various media related to the subject of cannabis and South Dakota. Words in italics are the thoughts of your truly at the time of reading the article.

'South Dakotans have delivered a crippling blow to those who favored the status quo of marijuana prohibition in the Mount Rushmore State by simultaneously passing a pair of ballot initiatives: Initiative Measure 26 and Constitutional Amendment A.

Constitutional Amendment A allows adults to purchase and possess up to one ounce of marijuana and grow up to three plants for personal use. Measure 26 permits qualified patients to possess and home-cultivate cannabis for medical purposes and establishes a state-regulated retail system for medical marijuana sales.'
https://norml.org/blog/2020/10/30/south-dakotans-green-light-marijuana-legalization-and-medical-access/

'Voters approved medical marijuana by an 82% margin, and 74% approved legalizing adult-use marijuana.

Assuming the results are upheld, the tribe will be the only one in the United States to create a cannabis market in a state where the plant is otherwise illegal. The tribal council plans to enact laws regarding how marijuana will be legalized and regulated.'
https://mjbizdaily.com/south-dakota-tribe-votes-to-legalize-marijuana-on-reservation/

'And, according to Armentano, all cannabis products, including marijuana and medical CBD, are illegal in Idaho, South Dakota, and Nebraska.'
https://www.webmd.com/pain-management/news/20190108/marijuana-hemp-cbd-whats-legal-and-where

'British pharmaceutical company GW Pharma and its American subsidiary Greenwich BioSciences are quietly moving proprietary CBD bills through at least two U.S. state legislatures, and could have plans for similar bills in other states.

The proposed measures, both taken from the same template, would effectively give GW/Greenwich a temporary monopoly on legal CBD products in South Dakota and Nebraska.

The pharmaceutical company’s lobbyists are moving in anticipation of the FDA’s expected approval of Epidiolex, a CBD-based drug that’s currently in Phase III clinical trials. Epidiolex has been developed by GW/Greenwich for the treatment of several rare childhood-onset epilepsy disorders. The company has been developing the drug for years, and FDA approval could come as early as this summer.'
https://www.leafly.com/news/politics/leafly-exclusive-gw-pharma-moving-cbd-bills-low